Latest filing published 26 Jul 2018 for Replimune Group, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -17.1%Entry US$15.00 · Close at T+365 US$12.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Forbion Capital Fund III Cooperatief U.A.: trading record in brief
All filings by Forbion Capital Fund III Cooperatief U.A. on record concern Replimune Group, Inc. In total, 4 filings cover trades dated 24 July 2018.
No open-market sale appears; the market trades are 1 purchase worth €1.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 26 July 2018, the filings show a transaction in Replimune Group, Inc. The latest purchase dates back some time: it was published 3,028 days ago, on 26 July 2018. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Forbion Capital Fund III Cooperatief U.A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 994,688 sharesCommon StockSEC:0001104659-18-047445:0
- 2,579,881 sharesCommon StockSEC:0001104659-18-047445:1
- 1,013,547 sharesCommon StockSEC:0001104659-18-047445:2
- 133,333 shares@ US$15.00100.0% of flowCommon StockSEC:0001104659-18-047445:3Canonical exit: 22 Oct 2018 (T+90)
4 of 4 declarations
